icon-    folder.gif   Conference Reports for NATAP  
 
  IAS 2015: 8th IAS Conference on
HIV Pathogenesis Treatment and Prevention
Vancouver, Canada
18-22 July 2015
Back grey_arrow_rt.gif
 
 
 
DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HIV-HCV COINFECTION: INTERIM ANALYSIS OF A FRENCH MULTICENTER COMPASSIONATE USE PROGRAM (AI444-258)
 
 
  Download the PDF here
 
Reported by Jules Levin
IAS 2015, July 19-22, 2015, Vancouver
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, Vancouver, Canada BC

IAS1.gif

K. Lacombe1, H. Fontaine2 , C. Dhiver3, E. Rosenthal4 , S. Metivier5, T. Antonini-Michelle6, MA. Valantin7, P. Miailhes8, S. Harent9, D. Batisse10, GP. Pageaux11, H. Aumaitre12, S. Dominguez13, J. Chas14, T. Allegre15, A. Lafeuillade16, P. De Truchis17, V. De Ledinghen18, V. Leroy19, E. Billaud20, P. Sogni21, F. Dabis22, L. Wittkop23, C. Duvivier24, A. Filipovics25, L. Fedchuk25, Y. Bennai25, D. Salmon26 on behalf of Bristol-Myers Squibb and ANRS CO13-HEPAVIH Cohort.
 
1Department of Infectious Diseases, St Antoine Hospital, APHP, Paris, France; 2Department of Hepatology, Cochin Hospital, APHP, Paris, France; 3Department of Infectious Diseases, Conception Hospital, AP-HM, Marseille, France; 4Department of Internal Medicine, Archet Hospital, University Hospital of Nice, Nice, France; 5Department of Digestive-Gastroenterology-Hepatology, Purpan University Hospital, Toulouse, France; 6Hepatobiliary Center, Paul-Brousse Hospital, APHP, Villejuif, France; 7Department of Infectious and Tropical Diseases, Pitie Salpetriere Hospital, Paris, France; 8Department of Infectious and Tropical Diseases, Lyon Civil Hospices, Lyon, France; 9Department of Infectious and Tropical Diseases, Bichat-Claude Bernard Hospital, Paris, France; 10Georges Pompidou European Hospital, APHP, Paris, France; 11Saint-Eloi University Hospital, Department of Hepato-Gastroenterology and Liver Transplantation, Montpellier, France; 12Saint-Jean Hospital, Perpignan, France; 13Henri Mondor Hospital, Creteil, France; 14Department of Infectious Diseases, UPMC Tenon Hospital, APHP, Paris; 15Pays d'Aix Hospital, Aix-en-Provence, France; 16Sainte-Musse Hospital, Toulon, France; 17Department of Infectious Diseases, Versailles St Quentin en Yvelines University, R Poincare Hospital, APHP, Garches, France; 18Liver Fibrosis Investigational Center, Haut-Leveque Hospital, Bordeaux University Hospital, Pessac, France; 19Grenoble University hospital, Hepato-Gastroenterology University Clinic, Grenoble, France & Inserrm, 823 Unity, Grenoble, France; 20Department of Infectious Diseases, Hotel-Dieu University Hospital, COREVIH Pays de la Loire, Nantes, France; 21Department of Hepathology, Cochin Hospital, APHP, Paris-Descartes University, Paris, France; 22INSERM U897 Center-Epidemiology-Biostatistics, INSERM, ISPED, Bordeaux, France & Department of Public Health, Bordeaux University Hospital, COREVIH, Bordeaux, France; 23INSERM U897 Center-Epidemiology-Biostatistics, INSERM, ISPED, Bordeaux, France & Department of Public Health, Bordeaux University Hospital, COREVIH, Bordeaux, France; 24Necker Hospital, Paris, France; 25Bristol-Myers Squibb Research and Development, Rueil-Malmaison, France; 26Maladies Infectieuses, Hopital Cochin, France

IAS1.gif

IAS2.gif

IAS3.gif

IAS4.gif

IAS5.gif

IAS6.gif

IAS7.gif

IAS8.gif

IAS9.gif

IAS10.gif

IAS11.gif

IAS12.gif

IAS13.gif